Evaluation of Ceftriaxone utilization among selected hospitals in Dar-es-Salaam, Tanzania

  • Mlugu Eulambius Department of Pharmaceutics, School of Pharmacy; Muhimbili University of Health and Allied Sciences, Tanzania
  • Nelson Osward Department of Pharmaceutics, School of Pharmacy; Muhimbili University of Health and Allied Sciences, Tanzania

Abstract

Objectives: Inappropriate use of ceftriaxone has been reported to increase treatment cost among patients. In addition, inappropriate use is a threat for resistance development. We assessed utilization of ceftriaxone among selected public and private hospitals in Dar es Salaam Tanzania.

Methods: Retrospective study was conducted from February to May 2017. Total of 600 patients’ medication records were included. Chi square test was used to compare appropriateness use of ceftriaxone between the hospitals. Significance level was set at 0.05 and the confidence level at 95%.


Results: Total of 330 (55%) and 270 (45%) patients were prescribed ceftriaxone for pre-operative prophylaxis, and treatment respectively. In overall, ceftriaxone was significantly utilized inappropriately in private hospital (72.3%) than in public hospital (60%) p=0.002 against the Tanzania standard treatment guideline. Ceftriaxone was more used inappropriately in private (87%) than the public hospital (69.2%) p<0.001 for prophylaxis. In contrary, for treatment indication ceftriaxone was more used inappropriately in public hospital (53.3%) than in private hospital (38.9%) p= 0.026.There were no records of sensitivity test in all the patients’ files.


Conclusion: We report inappropriately utilization of Ceftriaxone against the Tanzanian standard treatment guideline. Private hospital was found to utilize ceftriaxone more inappropriately than the public hospital. We recommend further prospective studies involving all antimicrobials to be done.


Keywords: Ceftriaxone utilization, antimicrobial resistance, inappropriate use

Downloads

Download data is not yet available.

Author Biographies

Mlugu Eulambius, Department of Pharmaceutics, School of Pharmacy; Muhimbili University of Health and Allied Sciences, Tanzania

Department of Pharmaceutics, School of Pharmacy; Muhimbili University of Health and Allied Sciences, Tanzania

Nelson Osward, Department of Pharmaceutics, School of Pharmacy; Muhimbili University of Health and Allied Sciences, Tanzania

Department of Pharmaceutics, School of Pharmacy; Muhimbili University of Health and Allied Sciences, Tanzania

References

REFERENCES
1. Ventola, C.L., The antibiotic resistance crisis: part 1: causes and threats. 2015. 40(4): p. 277-83.
2. CDC. Antibiotic Use in the United States, 2017: Progress and Opportunities. Atlanta, GA: US Department of Health and Human Services, CDC; 2017.
3. World Health Organization. Antimicrobial resistance, Global report on surveillance 2014. Geneva 2014, 2014.
4. Joseph, N.M., et al., Relationship between Antimicrobial Consumption and the Incidence of Antimicrobial Resistance in Escherichia coli and Klebsiella pneumoniae Isolates. Journal of clinical and diagnostic research : JCDR, 2015. 9(2): p. DC08-DC12.
5. Petri WA. Penicillins, Cephalosporins, and Other β-Lactam Antibiotics. In: Brunton LL, Chabner BA, BC K. Goodman & Gilman’s the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill; 2011
6. Fahimzad, A., et al., Surveillance of Antibiotic Consumption Point Prevalence Survey 2014: Antimicrobial Prescribing in Pediatrics Wards of 16 Iranian Hospitals. Arch Iran Med, 2016. 19(3): p. 204-9.
7. Iskandar, K., et al., Antibiotic consumption in non-teaching Lebanese hospitals: A cross-sectional study. Journal of Infection and Public Health, 2016. 9(5): p. 618-625.
8. Lee, H., et al., Evaluation of ceftriaxone utilization at multicenter study. The Korean journal of internal medicine, 2009. 24(4): p. 374-380.
9. Pinto Pereira, L.M., et al., Third generation cephalosporin use in a tertiary hospital in Port of Spain, Trinidad: need for an antibiotic policy. BMC Infectious Diseases, 2004. 4(1): p. 59.
10. Ayele, A.A., et al., Prospective evaluation of Ceftriaxone use in medical and emergency wards of Gondar university referral hospital, Ethiopia. Pharmacology research & perspectives, 2018. 6(1): p. e00383.
11. Negese S. G, M.A., Amsale M, Asmamaw D, Omer M, Tenaw A. , Evaluation of Ceftriaxone Use for Hospitalized Patients in Ethiopia: The Case of a Referral Hospital. IJPSR, 2017. 3:2.
12. United republic of Tanzania. Standard Treatment Guidelines and Essential Medicines List. Ministry of Health and Social Welfare. Fourth Edition, 2013.
13. Sileshi, A., et al., Evaluation of ceftriaxone utilization in medical and emergency wards of Tikur Anbessa specialized hospital: a prospective cross-sectional study. BMC pharmacology & toxicology, 2016. 17: p. 7-7.
14. 14. Hafte K, T.K., Azeb W, et al., Assessment-of-ceftriaxone-use-in-eastern-ethiopian-referral-hospital-a-retrospective-study. J Infectious Disease Med Microbiol. 2018;2(3):26-9.
15. Shimels, T., A.I. Bilal, and A. Mulugeta, Evaluation of Ceftriaxone utilization in internal medicine wards of general hospitals in Addis Ababa, Ethiopia: a comparative retrospective study. Journal of pharmaceutical policy and practice, 2015. 8: p. 26-26.
16. Ayinalem, G., et al., Drug use evaluation of ceftriaxone in medical ward of Dessie Referral Hospital, North East Ethiopia. International Journal of Basic & Clinical Pharmacology, 2013. 2(6): p. 711
Statistics
56 Views | 112 Downloads
How to Cite
Eulambius, M., & Osward, N. (2019). Evaluation of Ceftriaxone utilization among selected hospitals in Dar-es-Salaam, Tanzania. Journal of Drug Delivery and Therapeutics, 9(6), 7-11. https://doi.org/10.22270/jddt.v9i6.3662